Objective: This study aimed to systematically compare the outcomes of different types of interventional procedures offered for the treatment of headaches and targeted toward peripheral nerves based on available published literature. Background: Multiple procedural modalities targeted at peripheral nerves are being offered to patients for the treatment of chronic headaches. However, few resources exist to compare the effectiveness of these modalities. The objective of this study was to systematically review the literature to compare the published outcomes and effectiveness of peripheral nerve surgery, radiofrequency (RF) therapy, and peripheral nerve stimulators for chronic headaches, migraines, and occipital neuralgia. Methods: A broad literature search of the MEDLINE and CENTRAL (Cochrane) databases was undertaken. Relevant studies were selected by 2 independent reviewers and these results were narrowed further by the application of predetermined inclusion and exclusion criteria. Studies were assessed for quality, and data were extracted regarding study characteristics (study type, level of evidence, type of intervention, and number of patients) and objective outcomes (success rate, length of follow-up, and complications). Pooled analysis was performed to compare success rates and complications between modality types. Results: Of an initial 250 search results, 26 studies met the inclusion criteria. Of these, 14 articles studied nerve decompression, 9 studied peripheral nerve stimulation, and 3 studied RF intervention. When study populations and results were pooled, a total of 1253 patients had undergone nerve decompression with an 86% success rate, 184 patients were treated by nerve stimulation with a 68% success rate, and 131 patients were treated by RF with a 55% success rate. When compared to one another, these success rates were all statistically significantly different. Neither nerve decompression nor RF reported complications requiring a return to the operating room, whereas implantable nerve stimulators had a 31.5% rate of such complications. Minor complication rates were similar among all 3 procedures. Conclusions: Of the 3 most commonly encountered interventional procedures for chronic headaches, peripheral nerve surgery via decompression of involved peripheral nerves has been the best-studied modality in terms of total number of studies, level of evidence of published studies, and length of follow-up. Reported success rates for nerve decompression or excision tend to be higher than those for peripheral nerve stimulation or for RF, although poor study quantity and quality prohibit an accurate comparative analysis. Of the 3 procedures, peripheral nerve stimulator implantation was associated with the greatest number of complications. Although peripheral nerve surgery seems to be the interventional treatment modality that is currently best supported by the literature, better controlled and normalized high-quality studies will help to better define the specific roles for each type of intervention.
D
espite decades of research and a bevy of available treatments, headaches such as chronic migraine, occipital neuralgia, frontotemporal neuralgias, and tension headache continue to be a chronically debilitating group of disorders with no clear etiologic explanation and no definitive cure. 1 Some of the pharmacotherapies used to prevent or treat the pain of these disorders are themselves associated with adverse effects that may be undesirable to patients, particularly in the setting of chronic dependency. These conditions have stimulated interest among both patients and researchers in procedural interventions that may provide long-lasting relief without the need for ongoing treatment or systemic effects.
Owing in large part to the research efforts of Guyuron and colleagues, 2Y5 the past decade has seen a rise in the number of publications examining procedures for chronic headaches targeted at peripheral nerve tissues. Most of these articles describe one of 3 general types of procedures. Peripheral nerve surgery involves ''decompression'' of the targeted nerve from postulated mechanical impingement by incising or removing nearby muscles, fascia, or other surrounding tissues in the vicinity of the nerve; less commonly, the nerve itself is surgically excised (typically in the setting of failed decompression). Peripheral nerve stimulation (PNS) uses an implanted neuromodulation device and electrodes to electrically stimulate the targeted nerve, creating interference with normal sensory perception that may lead to pain relief. 6 Radiofrequency (RF) therapy involves the percutaneous insertion of a catheter (typically under f luoroscopic guidance) that is directed toward the nerve of interest and can be used either to ablate the nerve by thermal lesioning [RF ablation (RFA)], or to produce more poorly defined changes in nerve physiology through delivery of pulsed RF signals at sublethal intensity/frequency. 7 Radiofrequency ablation is an accepted treatment for cervical facet joint pain due to boney arthritis, but our clinical experience suggests that it is also used by some practitioners for headaches not of arthritic origin.
Previous review articles on the outcomes of nerve decompression for migraines have been unsystematic with a limited listing of relevant articles. 8 Furthermore, literature on surgical and other invasive treatments for migraines and cephalic neuralgias has been focused on outcomes of one treatment type in single cohorts, and targeted toward the surgeons or interventionalists most likely to adopt these procedures. To date, there has been no systematic attempt to compare the outcomes of different procedure types that share a goal of peripheral nerve manipulation for the treatment of headaches but differ in modality. The purpose of this article was to provide such information in a structured, systematic comparison to help guide consideration of these procedures by headache-care practitioners and their patients with chronic headaches.
''migraine,'' ''occipital neuralgia,'' and ''frontotemporal neuralgia.'' Additional studies were identified by reviewing the reference lists of relevant abstracts from the search results.
Selection Criteria and Quality Assessment
To avoid selection bias, specific inclusion and exclusion criteria were established before searching (Table 1) . Two reviewers (S.A.F. and J.M.F.), who were blinded to the journal, author, institution, and the article's date of publication, independently reviewed the full list of search results. Articles were selected first by title search looking for relevance, and then by abstract review, applying the selection criteria in Table 1 . Review articles, animal or preclinical studies, and studies with fewer than 10 subjects were excluded. Selected abstracts were further stratified by review of the full text of each study.
The population considered was patients of any age with chronic headaches who had undergone an invasive procedure targeted toward peripheral nerves of the head and neck. Most articles stated that patients were ''refractory to previous treatments,'' although this was variably defined. ''Chronic headaches'' or ''chronic daily headaches'' as well as ''chronic migraine headaches,'' or ''migraine headaches'' were included, as were headaches whose name references a peripheral nerve component such as ''occipital neuralgia,'' ''supraorbital neuralgia,'' and ''frontotemporal neuralgia.'' Other specific nonYmigraine headache types (eg, cluster, trigeminal neuralgia, and cervicogenic headache) without a purported relation to peripheral nerve etiology or treatment were excluded. ''Interventional'' was defined as a procedure that was either labeled ''surgical'' in the article, involved making permanent changes to peripheral nerves or surrounding tissues, or included implantation of a medical device. Procedures such as acupuncture or injectable medications that include temporary insertion of a device without an intention to cause permanent change in tissues were excluded. ''Peripheral nerve'' is defined as any nerve that is extradural and external to the bony spine/vertebrae or craniofacial skeleton.
Studies that met all of the inclusion criteria without meeting any of the exclusion criteria were considered eligible. Three-author consensus format was used to review the final list of included articles and to address interreviewer variability.
The level of evidence of each study was assessed using the University of Oxford Centre for Evidence-Based Medicine's levels of evidence (Table 2) .
Data Extraction
Two investigators (J.M.F. and S.A.F.) independently extracted data by using a structured form. The outcomes examined were the success rate of the intervention, rate and type of complications, and length of follow-up.
Data Analysis
Pooled analysis was performed for each treatment modality by dividing the total number of reported successes by the total number Individual cohort study or low-quality RCT 2c
Ecological study 3a
Systematic review of case-control studies 3b
Individual case-control study 4 Case series or poor-quality cohort or case-control study 5 Expert opinion FIGURE 1. Citation attrition diagram.
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of patients across all studies for that modality. W 2 analysis was used to test for differences in success rates between treatment types. The same methodology was used to analyze complication rates.
RESULTS
Study Inclusion
A citation attrition diagram is presented in Figure 1 . The stated literature search produced 250 articles from PubMed and 0 articles from the Cochrane Library. Two hundred eighteen of these articles were determined not to be relevant after title and abstract review, and a further 13 were eliminated after full-text review based on predefined inclusion and exclusion criteria, leaving 19 articles. Reference lists of all full-text articles were reviewed and this process produced an additional 7 articles meeting inclusion criteria. In total, 26 articles fulfilled our criteria and were included in the systematic review. Of these, 14 articles studied nerve decompression surgery, 9 articles studied PNS, and 3 articles studied RF intervention.
Study Quality
Of the available 26 articles, most were case series (Oxford level of evidence ''4'') and ''low-level'' evidence. Of the 14 articles studying surgical nerve decompression however, 3 were high-quality randomized-controlled trials (RCTs) with follow-up between 1 and 5 years (Oxford level 1b). Of the 9 articles studying nerve stimulation, 1 was an RCT and included 3 months of follow-up. No RCTs were found that studied RF intervention.
Population
Despite the use of broad search terms, articles meeting our inclusion criteria were limited to one of 3 types of procedures, namely, surgical nerve decompression, implantable nerve stimulation, and pulsed RF. There were no articles examining RFA of peripheral nerves for chronic migraines or chronic daily headaches. Several articles examined the use of RFA for cervicogenic headache, but these were excluded based on headache type. A total of 1253 patients were included in studies on nerve decompression, whereas 184 had undergone PNS and 131 underwent RF treatment.
Success Rate
''Success'' was defined variably among studies. Most studies sought a 50% reduction in quantified variables such as pain intensity, headache frequency, or headache duration, with a 50% reduction in pain on the visual analog scale being the most frequently used measure. Less frequently, more subjective measures such as ''complete relief,'' ''excellent relief,'' ''good relief,'' or ''patient satisfaction'' were used to describe procedural success. To minimize variability for the purposes of this review, success rate for each article was defined as the number of patients reporting a 50% reduction in headache pain, frequency, or duration if results were reported in enough detail to make this determination. If this rate could not be determined accurately from a detailed review of the Results section, the success rate was extracted from each article using the criteria defined by its authors; these criteria are included in Table 3 .
In the 14 studies on surgical decompression, success rates of individual articles ranged from 68% to 100% (Table 3A) . Pooled analysis yielded a total of 1253 patients and 1072 successes for an overall success rate of 86% (Table 4) .
In the 9 studies on PNS, success rates of individual articles ranged from 27% to 100% (Table 3B) . Pooled analysis yielded a total of 184 patients and 126 successes for an overall success rate of 68% (Table 4) . It should be noted that the number of subjects and success rates recorded for peripheral nerve stimulator studies in this review does not include the number of patients who underwent trial stimulation and failed. Only those patients who received an implantable device were included. Inclusion of those patients who were selected for stimulation but failed trial stimulation would further reduce the reported success rate.
In the 3 studies on pulsed RF treatment, success rates of individual articles ranged from 51% to 100% (Table 3C) . Pooled analysis yielded a total of 131 patients and 72 successes for an overall success rate of 55%.
All comparisons were statistically significantly different (surgery vs stimulation, P G 0.0001; surgery vs RF, P G 0.0001; RF vs stimulation, P = 0.0075) (Fig. 2) .
Complications
For the purposes of this review, major complications were defined as those requiring return to the operating room, whereas all other complications were defined as minor. Reporting in complications varied considerably between articles; however, several clear trends emerged in the types of complications related to each procedure.
Articles describing larger cohorts of surgical nerve decompression patients reported a relatively low but steady incidence of postoperative subjective complaints such as peri-incisional numbness, paresthesias, pruritus, stiffness, weakness, or hypersensitivity. Postoperative migraines were also reported as occasional complications. Minor surgical complications such as hematoma, cellulitis, or peri-incisional alopecia occurred less frequently. There were no reports of any surgical complication requiring return to the operating room in the nerve decompression group (Tables 3A and 5 ). Four articles in this group did not mention whether there were any complications.
Articles describing results of nerve stimulation tended to report a low but steady incidence of minor complications such as lead site pain, contact dermatitis, loss of effect, or current leak. However, there was a consistent tendency to report a high rate of major complications such as unintended lead ''migration,'' device infections, and faulty hardware that required reoperation either to remove or replace the device (Tables 3B and 5) . Table 5 , which reports the combined rate of minor and major complications among all studies, reports a 37% rate of minor complications and 31.5% rate of major complications for PNS. However, it should be noted that this number may be skewed by the large number (n = 56; 71% of subjects had complications) of complications reported in the RCT by Saper et al. Although Saper et al report that many of these complications consisted of infections, device migrations, and faulty leads/hardware, they did not report which of these required return to the operating room; possibly owing to the short follow-up period of the study (3 months). Therefore, although many of the reported complications in this study were likely to require reoperation, they were all considered ''minor'' complications in this review. On the basis of this and the numbers reported in Table 5 , it is likely that the true rate of complications requiring return to the operating room in the nerve stimulator group was in excess of 33%.
Among the articles studying pulsed RF, there was a low rate of minor complications, which typically consisted of new or worsened pain, and a zero rate of major complications requiring return to the operating room (Tables 3C and 5 ).
Follow-up
Follow-up periods were recorded in months; both averages and ranges were recorded when available (Table 3AYC) . If only ranges were reported, the study was considered to include greater than 1 year of follow-up if the higher end of its reported range exceeded 12 months.
All but one study on surgical nerve decompression reported follow-up of 1 year or more, with the longest reported follow-up being 5 years in an RCT (Tables 3A and 6 ). The range of follow-up periods was variable among studies on nerve stimulation, with 3 of 9 studies reporting follow-up of less than 1 year, but 4 studies reporting lengthy follow-up ranging from 32 to 87 months (Tables 3B and 6 ). All of these studies were lower-quality case series by the Oxford level. The only RCT among this group reported results at 3 months of follow-up.
None of the studies of pulsed RF included follow-up periods of 12 months or more (Table 6 ).
DISCUSSION
The results of this systematic review demonstrate that surgical nerve decompression, implantable nerve stimulation, and pulsed RF are the only 3 interventional procedures that treat chronic headaches by altering peripheral nerves and have been studied in the modern published literature. When these 3 modalities are compared systematically to provide patients and practitioners with evidence-based information, certain conclusions can be drawn readily and objectively.
First, the quality of available information is superior for surgical nerve decompression compared to other modalities. This is true both in the level of evidence of available studies as well as the sheer quantity of published studies. Thus, conclusions drawn from systematic review of this procedure should carry more weight than those drawn from the fewer and lower-quality studies describing nerve stimulation or pulsed RF.
Data from this review support a success rate on the order of 86% for surgical nerve decompression, which is relatively consistent across 14 available studies of different design, including both RCTs and case series. In contrast, a pooled success rate of 68% for nerve stimulation is at best a rough estimate, given the lower overall quality of information available, the wide range of reported success rates, and the rather stark disagreement between the singular available RCT (27% success) and remaining case series (60%Y100% success). Pulsed RF has the least available supporting evidence, but the wide range of reported success rates (51%Y100%) and lack of long-term follow-up make it reasonable to view this procedure as only modestly successful, at best, until better defined by future studies.
Results of this review also support a clear differentiation in the complication profile for each of the 3 procedures. The complications of surgical nerve decompression are best characterized as an inhomogeneous collection of minor physical and sensory disturbances related to the surgical site. These include the possibility of paresthesias, allodynia, pain, numbness, localized alopecia, and continuance or temporary provocation of migraines. Less commonly, bleeding or infection may result. The exact combination of adverse effects is likely surgeondependent. It is rare for a return to the operating room to be required because of a surgical complication. Peripheral nerve stimulation, in contrast, may be accompanied by local minor complications similar to those previously mentioned, but also has a very high rate of need for additional surgeries because of lead migration, hardware failure, or infection. Finally, pulsed RF seems to have a very low complication profile, with worsening of pain being the only reported negative effect. This is sensible given the nondestructive nature of the procedure.
The importance of this study is that it clearly delineates, based on peer-reviewed, published evidence, what is and is not known about the various interventional procedures for chronic headaches, migraines, and occipital and frontotemporal neuralgias. Although too much disparity exists between the number and types of studies available for different modalities to make a valid comparison between their outcomes, this review does provide a systematic overview and comparison of the state of the literature for each modality. This information should be useful to both patients and physicians who are weighing the option of an interventional therapy against continued pharmacotherapy. We believe that patients, in particular, may benefit from this report as otherwise their knowledge of their own options may be heavily biased by the treatments available from the particular headache practitioner who is treating them. Headache specialists may also find this information a useful reference during dialogues with both surgeons and those who manufacturer or advocate technology such as implantable stimulators and RF-based devices.
This article is limited by several factors, foremost of which is the strength of the available evidenceVmultiple relevant publications regarding PNS for occipital or supraorbital neuralgia were excluded because of either inadequate sample size (n G 10), 31Y35 or failure to report success rates based on clearly defined criteria. 36 Although a reasonable body of evidence exists in support of peripheral nerve surgery, further RCTs performed by other surgeons would certainly strengthen this evidence. The cases for nerve stimulation and pulsed RF would both benefit from high-quality RCTs with long-term follow-up.
The outcomes for all 3 procedures are clouded by inconsistent indications and inclusion protocols. As we have previously reported, 13 before undergoing any interventional procedure, all chronic migraine, headache, and neuralgia patients need to have the following: (1) undergone an exhaustive workup by a neurologist or another practitioner specialized in the medical diagnosis and treatment of headaches, (2) initiated medical treatment and proven refractory to medical management for at least 3 months, and (3) shown a positive response to either local anesthetic blockade of the indicated nerve, or Botox infiltration in the area around the nerve.
Regardless of potential classification or pathologic differences, these conditions might be met by patients carrying the diagnosis of ''migraine headaches,'' ''chronic migraine headaches,'' ''chronic daily headaches,'' ''occipital neuralgia,'' ''supraorbital/supratrochlear neuralgia,'' or ''frontotemporal neuralgia,'' which is why these headache types were included in our literature review. All of the articles included in this review studied patients with one of these diagnoses, but they differed in the stringency of applying the inclusion criteria listed previously. Thus, some series may have reported successes in patients who were not refractory to medical therapy, and some may have reported failures in patients who never responded to a nerve block and perhaps ought not to have been considered for therapy. Also, as mentioned in the Results section, success rates for nerve stimulation may be artificially ''concentrated'' by the exclusion of patients who undergo trial stimulation but fail and never receive a permanent implant: there is no equivalent ''trial period'' for other surgical procedures to help concentrate the group of responders. Again, prospective RCTs with strictly defined selection algorithms would reduce this variability. Finally, this review is limited by what is not included. Although we set broad search criteria, some articles (particularly on nerve stimulation) that would have added breadth to the review did not meet inclusion criteria for the systematic review based on small study size or poor reporting of results. 31Y36 However, there are doubtlessly other invasive procedures being used for chronic headache relief that do not even appear in the literature and so could not be included. The most striking example is RFA, which, unlike pulsed RF, causes a destructive thermal lesion of the targeted nerve. Radiofrequency ablation has been studied widely for trigeminal neuralgia (at the level of the ganglion), low back pain due to lumbar facet arthropathy, 37 and for the treatment of cervicogenic headache due to cervical zygapophyseal joint pathology. 38Y40 However, it is also frequently used by chronic pain specialists as an intervention for a variety of other, lesser studied pain states. In our experience, it is quite common for patients to present with chronic occipital neuralgia or migraines after having already undergone unsuccessful RFA of the C2 and C3 dorsal nerve branches for headaches not related to cervical arthropathy. Part of the stimulus to perform this systematic review was to identify success rates and complications of RFA applied in this ''off-label'' fashion for chronic headaches, however, none are apparently published that would qualify for inclusion (it should be again stressed that some meaningful studies have been performed examining the use of RFA in cervicogenic headache, but this condition is related to bony facet arthropathy at the level of the vertebral column and so it was not included in our study). Thus, it is a limitation of this study that we are not able to advise patients and practitioners on the safety or efficacy of some invasive techniques which seem to be in widespread use despite being underrepresented in the literature.
CONCLUSIONS AND RECOMMENDATIONS
In summary, for patients or practitioners considering treatment options for control of medically refractory chronic headaches, currently published evidence indicates that peripheral nerve surgery via decompression of involved peripheral nerves is the most studied modality in terms of total number of articles, level of evidence of published studies, and length of follow-up when compared to the 2 most common other options, namely, implantable nerve stimulators and pulsed RF. Reported success rates for nerve decompression or excision tend to be higher than those for PNS or for RF, although poor study quantity and quality preclude a reliable meta-analysis. Radiofrequency ablation, although commonly practiced, is not adequately reported in the literature to gain recommendation for the treatment of chronic headaches not of cervicogenic origin. Of the 3 studied interventions, peripheral nerve stimulators were associated with the greatest number of complications requiring return to the operating room. The presented work suggests that all interventional modalities for chronic headaches would benefit from a greater number of RCTs. 
